Language is not available For the sake of viewer convenience, the content is shown below in the alternative language. You may click the link to switch the active language.

The new measures aim at :

ensuring abundant availability, at reasonable prices, of essential life saving and prophylactic medicines of good quality;
strengthening the system of quality control over drug production and promoting the rational use of drugs in the country;
creating an environment conducive to channelising new investment into the pharmaceutical industry, to encouraging cost-effective production with economic sizes and to introducing new technologies and new drugs, and
strengthening the indigenous capability for production of dr

• औषधि नीति 1986
• Part II – Objectives
• Part III – Rational Use of Drugs
• Part IV-Quality Control
• Part V – Pricing
• Part VI – Licensing
• Part VII – Duty Rationalization
• Part VIII – Co-Ordination Between Health and Industry Ministries
• Part IX – Review
• Annexure I(Refer to Paragraph 6.1)
• Annexure – II (Refer to Paragraph 6.3)
• Annexure – III (Refer to Paragraph 6.8)